SCHEMBL27008244

SCHEMBL27008244

Fn1ccc(-c2cccnc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.50
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 4/20 0.50
CYP1A2 P05177 2/20 0.50
FYN P06241 2/20 0.45
CYP2E1 P05181 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2B6 P20813 2/20 0.45
CYP2C19 P33261 2/20 0.45
ALK Q9UM73 1/20 0.45
CYP19A1 P11511 2/20 0.44
METAP2 P50579 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9384083 0.79 KMT2A (0.62) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL1991928 0.78 KMT2A (0.59) ALDH1A1KDM4ELMNATP53MAPT
SCHEMBL21634194 0.78 CYP2A6 (0.50) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL28227590 0.78 CYP2A6 (0.50) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL2614253 0.78 CYP2A6 (0.50) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL27843224 0.75 CYP2A6 (0.47) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL27843225 0.75 CYP2A6 (0.47) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL14405046 0.74 CYP2A6 (0.54) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL6691985 0.74 CYP2A6 (0.45) CYP2A6ALDH1A1CYP3A4CYP1A2FYN
SCHEMBL6677484 0.74 ALDH1A1 (0.50) CYP2A6ALDH1A1CYP3A4CYP1A2FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS TRINEURO (KR) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018119-A1 CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS MAOA, DRD2, MAOB CYP2A6 391/4885ALDH1A1 1214/4885CYP3A4 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.